Mimedx (MDXG) Net Equity Issued and Repurchased (2011)
Mimedx (MDXG) reported Net Equity Issued and Repurchased of -$3.7 million for Q4 2011, down 3476.65% sequentially from $110867.0 in Q3 2011.
Mimedx (MDXG) Net Equity Issued and Repurchased (2011) Analysis & Trends
Mimedx (MDXG) has 1 years of Net Equity Issued and Repurchased data on file, last reported at -$3.7 million in Q4 2011.
- For the quarter ending Q4 2011, Net Equity Issued and Repurchased changed N/A year-over-year to -$3.7 million; the trailing twelve-month figure through Sep 2012 stood at -$3.7 million (changed N/A YoY), and the FY2020 full-year result was $100.0 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased eased to -$3.7 million in Q4 2011, from $110867.0 in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $2.4 million in Q2 2011 to a low of -$3.7 million in Q4 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 141.90 Mn |
| 10 | Mimedx | 635.35 Mn | 475.58 Mn | 41.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | -3.74 Mn |
| Dec 31, 2011 | -3.74 Mn |
| Sep 30, 2011 | 110,867.00 |
| Sep 30, 2011 | 110,867.00 |
| Jun 30, 2011 | 2.42 Mn |
| Jun 30, 2011 | 2.42 Mn |
| Mar 31, 2011 | 1.21 Mn |
| Mar 31, 2011 | 1.21 Mn |